Study Published in Journal of Clinical Investigation Insight Demonstrates Ability to Predict Early Rejection in Kidney Transplant with FractalDx Portfolio Technology
Positive study results support successful development of a predictive blood test for transplant patients to meet critical unmet medical need
NEW YORK, June 7, 2019 -- (Healthcare Sales & Marketing Network) -- Renalytix AI plc (AIM: RENX), a developer o... Diagnostics RenalytixAI, FractalDx, transplant rejection
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Kidney Transplant | Kidney Transplantation | Marketing | Pharmaceuticals | Study | Transplant Surgery | Transplants | Urology & Nephrology